Literature DB >> 25363453

The role of lifestyle change for prevention of cardiovascular disease in diabetes.

Lisa R Staimez1, Mary Beth Weber, Edward W Gregg.   

Abstract

The burden of cardiovascular disease (CVD) is disproportionately greater in those with diabetes than in the general population, including higher rates of hospitalization, stroke, myocardial infarction, and mortality. Health-promoting lifestyle factors reduce both diabetes and CVD in healthy individuals; however, the efficacy of these strategies for CVD reduction in people with preexisting diabetes is unclear. In this review, we describe the most recent evidence (2013-2014) surrounding the effects of lifestyle changes on CVD outcomes in those with diabetes, and we contextualize the evidence against a backdrop of earlier key findings. Two major randomized controlled trials were identified, providing opposing conclusions about the role of lifestyle factors on CVD events in those with diabetes. Other recent prospective observational analyses support associations of physical activity and reduced CVD risk in diabetes. Limitations across studies include the use of self-report for measurement of lifestyle or lifestyle change, the length of follow-up needed to measure CVD outcomes, and the role of participants' medications on associations of lifestyle factors and CVD outcomes. Equivocal findings from the two randomized controlled trials support the need for additional research to identify the specific lifestyle factors that reduce CVD mortality and macrovascular complications in populations with diabetes.

Entities:  

Mesh:

Year:  2014        PMID: 25363453     DOI: 10.1007/s11883-014-0460-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  42 in total

Review 1.  Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis.

Authors:  Elizabeth Sumamo Schellenberg; Donna M Dryden; Ben Vandermeer; Christine Ha; Christina Korownyk
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

2.  Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.

Authors:  Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros
Journal:  Ann Intern Med       Date:  2006-07-04       Impact factor: 25.391

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial.

Authors:  Miguel Ruiz-Canela; Ramón Estruch; Dolores Corella; Jordi Salas-Salvadó; Miguel A Martínez-González
Journal:  JAMA       Date:  2014 Jan 22-29       Impact factor: 56.272

5.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

6.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

7.  The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus.

Authors:  J I Blomster; C K Chow; S Zoungas; M Woodward; A Patel; N R Poulter; M Marre; S Harrap; J Chalmers; G S Hillis
Journal:  Diabetes Obes Metab       Date:  2013-06-11       Impact factor: 6.577

8.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

9.  Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Authors:  Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

10.  Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes.

Authors:  Donald A Williamson; Jack Rejeski; Wei Lang; Brent Van Dorsten; Anthony N Fabricatore; Katie Toledo
Journal:  Arch Intern Med       Date:  2009-01-26
View more
  4 in total

1.  Health and Economics of Lifestyle Medicine Strategies.

Authors:  Dee W Edington; Wayne N Burton; Alyssa B Schultz
Journal:  Am J Lifestyle Med       Date:  2020-02-22

2.  Trends in Lifestyle Counseling for Adults With and Without Diabetes in the U.S., 2005-2015.

Authors:  Megha K Shah; Miranda A Moore; K M Venkat Narayan; Mohammed K Ali
Journal:  Am J Prev Med       Date:  2019-11       Impact factor: 5.043

Review 3.  Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

Authors:  Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick
Journal:  Cardiovasc Diabetol       Date:  2017-12-04       Impact factor: 9.951

4.  In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions.

Authors:  Yuanmin Li; Jing Ni; Rong Guo; Weiming Li
Journal:  Biomed Res Int       Date:  2016-03-31       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.